doi: 10.1186/s13048-019-0555-8
Genetic epidemiology of insulin resistance and visceral adiposity
A glucagon-like peptide-1 receptor agonist, semaglutide, mimics the action of a natural hormone called GLP-1, reducing blood sugar levels by stimulating insulin secretion and reducing glucagon secretion
At the end of the 24-week study, participants in the 1.0 mg, 3.0 mg, 4.5 mg, and 6.0 mg HRS9531 groups achieved weight loss of 5.4%, 13.4%, 14.0%, and 16.8%, respectively, compared with 0.1% in the placebo group
Multiple structural grafts were placed to support the nose, improve contour, and maintain long-term stability
This legal protection ensures the innovating companies recoup research and development investments, but it creates significant affordability barriers for individuals seeking weight loss therapy